NuCana Stock (NASDAQ: NCNA) stock price, news, charts, stock research, profile.
Open | $3.753 |
Close | $3.520 |
Volume / Avg. | 9.584K / 80.918K |
Day Range | 3.520 - 3.753 |
52 Wk Range | 3.400 - 23.750 |
Market Cap | $8.499M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 1.38% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NuCana (NASDAQ: NCNA) through any online brokerage.
Other companies in NuCana’s space includes: Entero Therapeutics (NASDAQ:ENTO), Addex Therapeutics (NASDAQ:ADXN), Coeptis Therapeutics (NASDAQ:COEP), BioRestorative Therapies (NASDAQ:BRTX) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for NuCana (NASDAQ: NCNA) was reported by Oppenheimer on Monday, April 1, 2024. The analyst firm set a price target for 4.00 expecting NCNA to rise to within 12 months (a possible 6.67% upside). 4 analyst firms have reported ratings in the last year.
The stock price for NuCana (NASDAQ: NCNA) is $3.75 last updated May 24, 2024 at 7:20 PM EDT.
There are no upcoming dividends for NuCana.
NuCana’s Q2 earnings are confirmed for Wednesday, August 14, 2024.
There is no upcoming split for NuCana.
NuCana is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.